The higher risk to develop worse outcomes in diabetic population infected with SARS-CoV-2 (Apicella et al., 2020) also can be associated with the reduced ACE2/ACE ratio in diabetic condition, which could be critical to several pathophysiological mechanisms of COVID-19 (Roca-Ho et al., 2017). This evidence concerns the gene ACE2 and COVID-19.